UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2018-03, Vol.36 (7), p.642-651

2018

Volltextzugriff (PDF)

Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study

Journal of clinical oncology, 2008-03, Vol.26 (8), p.1331-1337

2008

Volltextzugriff (PDF)

Phase II Study of Neoadjuvant Chemotherapy and Radiation Therapy in the Management of High-Risk, High-Grade, Soft Tissue Sarcomas of the Extremities and Body Wall: Radiation Therapy Oncology Group Trial 9514

Journal of clinical oncology, 2006-02, Vol.24 (4), p.619-625

2006

Volltextzugriff (PDF)

TET2 Mutations Improve the New European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

Journal of clinical oncology, 2011-04, Vol.29 (10), p.1373-1381

2011

Volltextzugriff (PDF)

Effects of Pretransplantation Treatment With Rituximab on Outcomes of Autologous Stem-Cell Transplantation for Non-Hodgkin's Lymphoma

Journal of clinical oncology, 2004-11, Vol.22 (22), p.4561-4566

2004

Volltextzugriff (PDF)

Phase I Study of Oblimersen Sodium, an Antisense to Bcl-2, in Untreated Older Patients With Acute Myeloid Leukemia: Pharmacokinetics, Pharmacodynamics, and Clinical Activity

Journal of clinical oncology, 2005-05, Vol.23 (15), p.3404-3411

2005

Volltextzugriff (PDF)

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas

Journal of clinical oncology, 1993-07, Vol.11 (7), p.1269-1275

1993

Volltextzugriff (PDF)

Clinical Cancer Advances 2005: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology

Journal of clinical oncology, 2006-01, Vol.24 (1), p.190-205

2006

Volltextzugriff (PDF)

Phase III Multicenter Trial of Doxorubicin Plus Cyclophosphamide Followed by Paclitaxel Compared With Doxorubicin Plus Paclitaxel Followed by Weekly Paclitaxel As Adjuvant Therapy for Women With High-Risk Breast Cancer

Journal of clinical oncology, 2010-06, Vol.28 (18), p.2958-2965

2010

Volltextzugriff (PDF)

Breast and Ovarian Cancer Risk and Risk Reduction in Jewish BRCA1/2 Mutation Carriers

Journal of clinical oncology, 2012-04, Vol.30 (12), p.1321-1328

2012

Volltextzugriff (PDF)

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group

Journal of clinical oncology, 1989-11, Vol.7 (11), p.1602-1613

1989

Volltextzugriff (PDF)

Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol

Journal of clinical oncology, 1996-08, Vol.14 (8), p.2250-2257

1996

Volltextzugriff (PDF)

Adverse events affecting the mouth in two clinical trials of BEMA (BioErodible MucoAdhesive) Fentanyl

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.20648-20648

2008

Volltextzugriff (PDF)

Uterine cancer (Ut Ca) following risk-reducing salpingo-oophorectomy (RRSO) in women with BRCA mutations ( BRCA +): A multicenter, prospective study

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.1504-1504

2015

Volltextzugriff (PDF)

The use of subcutaneous natural ghrelin to treat cachexia (CC)-related symptom distress, nutritional intake (NI), and physical functioning: A two-step phase I/II study with an intrapatient dose escalation followed by maintenance treatment

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.TPS234-TPS234

2011

Volltextzugriff (PDF)

ICRF-187 permits longer treatment with doxorubicin in women with breast cancer

Journal of clinical oncology, 1992-01, Vol.10 (1), p.117-127

1992

Volltextzugriff (PDF)

Randomized, phase III study of adjuvant doxorubicin plus cyclophosphamide (AC) → docetaxel (T) with or without capecitabine (X) in high-risk early breast cancer: Exploratory Ki-67 analyses

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.500-500

2011

Volltextzugriff (PDF)

Cancer care during the last phase of life

Journal of clinical oncology, 1998-05, Vol.16 (5), p.1986-1996

1998

Volltextzugriff (PDF)

The safety of BEMA (BioErodible MucoAdhesive) Fentanyl for breakthrough pain (BTP) in cancer patients

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.20586-20586

2008

Volltextzugriff (PDF)

Absorption and tolerability of BEMA (BioErodible MucoAdhesive) fentanyl in cancer subjects with grade 1 mucositis

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.20559-20559

2008

Volltextzugriff (PDF)

Rapid, effective, and sustained control of breakthrough pain (BTP) in cancer patients treated with BEMA (BioErodible MucoAdhesive) fentanyl

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.9600-9600

2008

Volltextzugriff (PDF)

Lenalidomide in solid tumor patients with inflammatory cancer cachexia: A multicenter, randomized, double-blind, proof-of-concept study of fixed dose or CRP-response-guided dose or placebo

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.TPS239-TPS239

2011

Volltextzugriff (PDF)

Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma : final results of an intergroup trial

Journal of clinical oncology, 1994-06, Vol.12 (6), p.1164-1168

1994

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)

Publikationsform

Artikel
(52)

Sprache

Englisch
(52)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Humans
(22)
Life Sciences & Biomedicine
(20)
Oncology
(20)
Science & Technology
(20)
Female
(19)
Middle Aged
(19)
Aged
(16)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Adult
(14)
Male
(14)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(12)
Tumors
(9)
Aged, 80 And Over
(8)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(7)
Doxorubicin - Administration & Dosage
(7)
Doxorubicin - Adverse Effects
(6)
Pharmacology. Drug Treatments
(6)
Survival Rate
(6)
Treatment Outcome
(6)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
(52)
Journals@Ovid Ovid Full Text
(52)
Single Journals
(52)
IngentaConnect Journals
(30)
IngentaConnect
(30)
MEDLINE
(22)

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

J Clin Oncol
(1)

Menü

Weitere Dienste

Einstellungen

Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer

Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study

Phase II Study of Neoadjuvant Chemotherapy and Radiation Therapy in the Management of High-Risk, High-Grade, Soft Tissue Sarcomas of the Extremities and Body Wall: Radiation Therapy Oncology Group Trial 9514

Clinicopathologic Features and Response to Therapy of NRG1 Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter Registry

TET2 Mutations Improve the New European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission

Effects of Pretransplantation Treatment With Rituximab on Outcomes of Autologous Stem-Cell Transplantation for Non-Hodgkin's Lymphoma

Phase I Study of Oblimersen Sodium, an Antisense to Bcl-2, in Untreated Older Patients With Acute Myeloid Leukemia: Pharmacokinetics, Pharmacodynamics, and Clinical Activity

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas

Clinical Cancer Advances 2005: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology

Phase III Multicenter Trial of Doxorubicin Plus Cyclophosphamide Followed by Paclitaxel Compared With Doxorubicin Plus Paclitaxel Followed by Weekly Paclitaxel As Adjuvant Therapy for Women With High-Risk Breast Cancer

Breast and Ovarian Cancer Risk and Risk Reduction in Jewish BRCA1/2 Mutation Carriers

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group

Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol

Adverse events affecting the mouth in two clinical trials of BEMA (BioErodible MucoAdhesive) Fentanyl

Uterine cancer (Ut Ca) following risk-reducing salpingo-oophorectomy (RRSO) in women with BRCA mutations ( BRCA +): A multicenter, prospective study

The use of subcutaneous natural ghrelin to treat cachexia (CC)-related symptom distress, nutritional intake (NI), and physical functioning: A two-step phase I/II study with an intrapatient dose escalation followed by maintenance treatment

ICRF-187 permits longer treatment with doxorubicin in women with breast cancer

Randomized, phase III study of adjuvant doxorubicin plus cyclophosphamide (AC) → docetaxel (T) with or without capecitabine (X) in high-risk early breast cancer: Exploratory Ki-67 analyses

Cancer care during the last phase of life

The safety of BEMA (BioErodible MucoAdhesive) Fentanyl for breakthrough pain (BTP) in cancer patients

Absorption and tolerability of BEMA (BioErodible MucoAdhesive) fentanyl in cancer subjects with grade 1 mucositis

Rapid, effective, and sustained control of breakthrough pain (BTP) in cancer patients treated with BEMA (BioErodible MucoAdhesive) fentanyl

Lenalidomide in solid tumor patients with inflammatory cancer cachexia: A multicenter, randomized, double-blind, proof-of-concept study of fixed dose or CRP-response-guided dose or placebo

Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma : final results of an intergroup trial

Aktive Filter

Suchergebnisse filtern